Robert Cathery, a non-executive director of AIM miner Central Asia Metals sold £2.6m of shares at a price of 168.75p, a few days after the company put out its interim results and 10 days before the shares's ex-dividend date. Having sold 1.5m shares held by himself, his wife and family trust, the three parties still held 2.1m shares, representing roughly 1.9% of the company.At its interim results, Central Asia declared an interim dividend 5p per share, up 25% on the 2013 interim dividend. The dividend will be paid to shareholders registered on 10 October 2014, with Cathery making the sale on 30 September.The company is not strapped for funds, with cash and cash equivalents of $29m as at 30 June 2014 together with $12.7m in trade receivables which were subsequently received in July 2014.Top Director BuysGlaxoSmithKline (GSK) Director name: Sir Sir Deryck MaughanAmount purchased: 3,059 @ 1,428.17p Value: £43,688GlaxoSmithKline (GSK) Director name: Sir Sir Christopher GentAmount purchased: 4,395 @ 1,422.00p Value: £62,497GlaxoSmithKline (GSK) Director name: Dr Daniel (Dan) PodolskyAmount purchased: 2,295 @ 1,428.17p Value: £32,777GlaxoSmithKline (GSK) Director name: Ms Lynn ElsenhansAmount purchased: 2,281 @ 1,428.17p Value: £32,577Berkeley Group Holdings (The) (BKG) Director name: Mr Gregory J FryAmount purchased: 2,200 @ 2,263.00p Value: £49,786GlaxoSmithKline (GSK) Director name: Mr Dr Stephanie BurnsAmount purchased: 1,267 @ 1,428.17p Value: £18,095TT Electronics (TTG) Director name: Mr Richard TysonAmount purchased: 14,880 @ 168.00p Value: £24,998EKF Diagnostics Holdings (EKF) Director name: Mr David EvansAmount purchased: 100,000 @ 23.00p Value: £23,000GlaxoSmithKline (GSK) Director name: Ms Judy LewentAmount purchased: 983 @ 1,428.17p Value: £14,039Top Director SellsCentral Asia Metals (CAML) Director name: Mr Robert CatheryAmount purchased: 2,365,445 @ 168.75p Value: £3,991,688VP (VP.) Director name: Ms Allison BainbridgeAmount sold: 23,000 @ 610.50p Value: £140,415